Tim Elliott (@tim_tje) 's Twitter Profile
Tim Elliott

@tim_tje

Kidani Professor of Immuno-oncology at the University of Oxford. Fellow of Oriel College. Editor in Chief Immunotherapy advances @IMTadvances @britsocimm

ID: 494021285

calendar_today16-02-2012 12:49:59

634 Tweet

571 Followers

174 Following

Immunotherapy Advances Journal (@imtadvances) 's Twitter Profile Photo

Read our latest Special Collection led by Dr Adriana Bonomo Fiocruz in English ⭐ This collection includes 5 reviews & research articles on engineered #Tcells as a treatment option for #cancer 🎯 #OpenAccess read here 🔓bit.ly/3Nh04aJ

Read our latest Special Collection led by Dr Adriana Bonomo <a href="/fiocruz_en/">Fiocruz in English</a> ⭐

This collection includes 5 reviews &amp; research articles on engineered #Tcells as a treatment option for #cancer 🎯

#OpenAccess read here 🔓bit.ly/3Nh04aJ
Tim Elliott (@tim_tje) 's Twitter Profile Photo

Looking forward to participating in this discussion at Science Museum London this evening. Oxford Cancer sciencemuseum.org.uk/see-and-do/how…

British Society for Immunology (@britsocimm) 's Twitter Profile Photo

💫Huge congratulations from us to the Oxford-AstraZeneca Vaccine Team for being awarded the The Royal Society Copley Medal to recognise their achievement in developing & deploying a #COVID19 vaccine - very well deserved! 👏👏👏 #RSMedals

Tim Elliott (@tim_tje) 's Twitter Profile Photo

Today, the new British Society for Immunology journal Discovery Immunology Discovery Immunology Journal has officially presented its first issue: bit.ly/3V1FsrD. As EiC of Immunotherapy Advances Journal, it’s great to see so many high-quality articles from our newest sibling journal – congratulations to all involved!

Tim Elliott (@tim_tje) 's Twitter Profile Photo

I support #OA. It widens access to high quality research articles and that’s a good thing. We need to work on a funding model that supports a more diverse authorship.

Immunotherapy Advances Journal (@imtadvances) 's Twitter Profile Photo

Despite of success of #ICI & CAR #TcellTherapy for cancers, not all patients respond & some only experience short-term responses or toxic effects This review explores technologies such as #GeneEditing & synthetic biology to advance cancer #immunotherapy bit.ly/3IAzExG

Despite of success of #ICI &amp; CAR #TcellTherapy for cancers, not all patients respond &amp; some only experience short-term responses or toxic effects

This review explores technologies such as #GeneEditing &amp; synthetic biology to advance cancer #immunotherapy bit.ly/3IAzExG
Immunotherapy Advances Journal (@imtadvances) 's Twitter Profile Photo

Plasma exchange (PLEX) for severe immune-related adverse events from #CheckpointInhibitors Tamiko Katsumoto et al. Stanford Immunology review the current guidance & posit that timing may be a critical factor when using PLEX for life-threatening #irAEs ➡️bit.ly/3txdK9w

Dr Lennard Lee (Oxford University) (@drlennardlee) 's Twitter Profile Photo

1/x 🧵 Many patients, oncologists & cancer charities have DM me to ask🧐- "Can #Cancervaccine work, or is it a long shot. This is relevant, as the #uklaunchpad promises to give access to 10,000 cancer patients starting in 32 weeks.

Tim Elliott (@tim_tje) 's Twitter Profile Photo

I'm fundraising for Alzheimer's Society. Check out my JustGiving page and please donate if you can. Thank you! #JustGiving justgiving.com/fundraising/ti…

Tim Elliott (@tim_tje) 's Twitter Profile Photo

An outstanding network of basic and translational immunologists and local biotech. Plus keynote from Mike Dustin. What a day!

British Society for Immunology (@britsocimm) 's Twitter Profile Photo

Looking to publish your latest research on manipulations of the #ImmuneSystem? 🎯 With fast turnaround times, #PubMedCentral indexing & APC discount for BSI members, our #OA journal Immunotherapy Advances Journal is the perfect home for your next #immunotherapy paper: bit.ly/ITA-submit